litlas
ログインアカウント作成

Amedeo Lonardo

1996–2026 年に発表

123
論文数
19,118
被引用数
68
h 指数
111
i10 指数

被引用数

Amedeo Lonardo の年別被引用数1991 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 3 件2000 年: 被引用 1 件2001 年: 被引用 6 件2002 年: 被引用 13 件2003 年: 被引用 7 件2004 年: 被引用 13 件2005 年: 被引用 44 件2006 年: 被引用 33 件2007 年: 被引用 37 件2008 年: 被引用 30 件2009 年: 被引用 48 件2010 年: 被引用 46 件2011 年: 被引用 42 件2012 年: 被引用 49 件2013 年: 被引用 75 件2014 年: 被引用 111 件2015 年: 被引用 144 件2016 年: 被引用 160 件2017 年: 被引用 241 件2018 年: 被引用 175 件2019 年: 被引用 735 件2020 年: 被引用 919 件2021 年: 被引用 1,174 件2022 年: 被引用 954 件2023 年: 被引用 680 件2024 年: 被引用 1,125 件2025 年: 被引用 687 件2026 年: 被引用 32 件1992〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,496 件、この内訳の 17.2%中国: 引用元論文 1,226 件、この内訳の 14.1%イタリア: 引用元論文 814 件、この内訳の 9.4%イギリス: 引用元論文 517 件、この内訳の 5.9%ドイツ: 引用元論文 300 件、この内訳の 3.5%韓国: 引用元論文 259 件、この内訳の 3%スペイン: 引用元論文 255 件、この内訳の 2.9%カナダ: 引用元論文 221 件、この内訳の 2.5%日本: 引用元論文 209 件、この内訳の 2.4%オーストラリア: 引用元論文 201 件、この内訳の 2.3%フランス: 引用元論文 196 件、この内訳の 2.3%インド: 引用元論文 166 件、この内訳の 1.9%
0%17.2%その他 32.6%

機関

分野

  • Medicine84.6%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Immunology and Microbiology1.3%
  • Neuroscience0.9%
  • Nursing0.7%
  • Agricultural and Biological Sciences0.7%
  • その他3.6%

トピック

  • Liver Disease Diagnosis and Treatment22.9%
  • Diet, Metabolism, and Disease6.6%
  • Liver Disease and Transplantation5.1%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.8%
  • Alcohol Consumption and Health Effects3.4%
  • Hepatitis C virus research2%
  • その他55.2%

共著者

全論文

検索で開く
  1. Sex and gender: modifiers of health, disease, and medicine

    著者: Franck Mauvais‐Jarvis, C. Noel Bairey Merz, Peter J. Barnes, Roberta Dı́az Brinton, Juan Jesús Carrero, Dawn L. DeMeo, Geert J. De Vries, C. Neill Epperson, Ramaswamy Govindan, Sabra L. Klein, Amedeo Lonardo, Pauline M. Maki, Louise D. McCullough, Vera Regitz‐Zagrosek, Judith G. Regensteiner, Joshua B. Rubin, Kathryn Sandberg, Ayako Suzuki - The Lancet 2020 被引用: 1,989

  2. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps

    著者: Amedeo Lonardo, Fabio Nascimbeni, Stefano Ballestri, DeLisa Fairweather, Sanda Win, Tin Aung Than, Manal F. Abdelmalek, Ayako Suzuki - Hepatology 2019 被引用: 1,052

  3. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

    著者: Giovanni Targher, Christopher D. Byrne, Amedeo Lonardo, Giacomo Zoppini, Corrado Barbui - Journal of Hepatology 2016 被引用: 1,410

  4. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

    著者: Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, Giovanni Targher - Journal of Hepatology 2017 被引用: 736

  5. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis

    著者: Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Amedeo Lonardo, Jörn M. Schattenberg, Herbert Tilg, Christopher D. Byrne, Giovanni Targher - Gut 2020 被引用: 376

  6. Global burden of metabolic diseases, 1990–2021

    著者: Huai Zhang, Xiaodong Zhou, Michael D. Shapiro, Gregory Y.H. Lip, Herbert Tilg, Luca Valenti, Virend K. Somers, Christopher D. Byrne, Giovanni Targher, Wah Yang, Octavio Viveiros, Christopher Opio, Christos S. Mantzoros, John Ryan, Kenneth Yuh Yen Kok, Nozim Adxamovich Jumaev, Nilanka Perera, Andrew Gerard Robertson, Adam Abu-Abeid, Anoop Misra, Yu Jun Wong, Elena Ruiz‐Úcar, Орал Оспанов, Mehmet Kızılkaya, Fei Luo, Nahúm Méndez‐Sánchez, Mauricio Zuluaga, Amedeo Lonardo, Hazem Al Momani, Carlos J. Toro‐Huamanchumo, Leon A. Adams, Said A. Al‐Busafi, Ala I. Sharara, Wah‐Kheong Chan, Syed Imran Abbas, Silvia Sookoian, Sombat Treeprasertsuk, Ponsiano Ocama, Khalid Alswat, Alice P.S. Kong, Karim Ataya, Michelle Ching Lim-Loo, Rodolfo J. Oviedo, Olivia Szepietowski, Yasser Fouad, Huijie Zhang, Tamer N Abdelbaki, Christos S. Katsouras, Arun Prasad, Omar Thaher, Arshad Ali, Gabriel A Molina, Ki‐Chul Sung, Qin‐Fen Chen, Cosmas Rinaldi Adithya Lesmana, Ming‐Hua Zheng - Metabolism 2024 被引用: 302

  7. Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

    著者: Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Amedeo Lonardo, Giovanni Targher - Metabolites 2021 被引用: 295

  8. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk

    著者: Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Amedeo Lonardo - Advances in Therapy 2017 被引用: 555

  9. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis

    著者: Stefano Ballestri, Stefano Zona, Giovanni Targher, Dante Romagnoli, Enrica Baldelli, Fabio Nascimbeni, Alberto Roverato, Giovanni Guaraldi, Amedeo Lonardo - Journal of Gastroenterology and Hepatology 2015 被引用: 724

  10. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

    著者: Xiaodong Zhou, Qin‐Fen Chen, Wah Yang, Mauricio Zuluaga, Giovanni Targher, Christopher D. Byrne, Luca Valenti, Fei Luo, Christos S. Katsouras, Omar Thaher, Anoop Misra, Karim Ataya, Rodolfo J. Oviedo, Alice P.S. Kong, Khalid Alswat, Amedeo Lonardo, Yu Jun Wong, Adam Abu-Abeid, Hazem Al Momani, Arshad Ali, Gabriel A Molina, Olivia Szepietowski, Nozim Adxamovich Jumaev, Mehmet Kızılkaya, Octavio Viveiros, Carlos J. Toro‐Huamanchumo, Kenneth Yuh Yen Kok, Орал Оспанов, Syed Imran Abbas, Andrew Gerard Robertson, Yasser Fouad, Christos S. Mantzoros, Huijie Zhang, Nahúm Méndez‐Sánchez, Silvia Sookoian, Wah‐Kheong Chan, Sombat Treeprasertsuk, Leon A. Adams, Ponsiano Ocama, John Ryan, Nilanka Perera, Ala I. Sharara, Said A. Al‐Busafi, Christopher Opio, Manuel Garcia, Michelle Ching Lim-Loo, Elena Ruiz‐Úcar, Arun Prasad, Anna Casajoana, Tamer N. Abdelbaki, Ming‐Hua Zheng - EClinicalMedicine 2024 被引用: 191

  11. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

    著者: Giovanni Targher, Amedeo Lonardo, Christopher D. Byrne - Nature Reviews Endocrinology 2017 被引用: 397

  12. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

    著者: Matteo Ricchi, Maria Rosaria Odoardi, Lucia Carulli, Claudia Anzivino, Stefano Ballestri, Adriano Pinetti, Luca Fantoni, Fabio Marra, Marco Bertolotti, Sebastiano Banni, Amedeo Lonardo, Nicola Carulli, Paola Loria - Journal of Gastroenterology and Hepatology 2009 被引用: 629

  13. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

    著者: Amedeo Lonardo, Fernando Bril, Stephen H. Caldwell, Mohammed Eslam, Jian‐Gao Fan, Robert G. Gish, Henning Grønbæk, Sanal Madhusudana Girija, Norbert Stefan, Ayako Suzuki, Giovanni Targher, Herbert Tilg, Ming‐Lung Yu, Ming‐Hua Zheng, Jacob George - Journal of Hepatology 2024 被引用: 33

  14. Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both

    著者: Xiaodong Zhou, Amedeo Lonardo, Calvin Q. Pan, Michael D. Shapiro, Ming‐Hua Zheng - Journal of Hepatology 2024 被引用: 40

  15. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research

    著者: Amedeo Lonardo, Ayako Suzuki - Journal of Clinical Medicine 2020 被引用: 129

  16. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

    著者: Alessandro Mantovani, Fabio Nascimbeni, Amedeo Lonardo, Giacomo Zoppini, Enzo Bonora, Christos S. Mantzoros, Giovanni Targher - Thyroid 2018 被引用: 152

  17. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications

    著者: Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, György Baffy - International Journal of Molecular Sciences 2022 被引用: 65

  18. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation

    著者: Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, Amedeo Carraro, Christopher D. Byrne, Giovanni Targher - Nature Reviews Endocrinology 2022 被引用: 63

  19. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis

    著者: Alessandro Mantovani, Gianluigi Zaza, Christopher D. Byrne, Amedeo Lonardo, Giacomo Zoppini, Enzo Bonora, Giovanni Targher - Metabolism 2017 被引用: 358

  20. History of Nonalcoholic Fatty Liver Disease

    著者: Amedeo Lonardo, Simona Leoni, Khalid Alswat, Yasser Fouad - International Journal of Molecular Sciences 2020 被引用: 140

  21. Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction

    著者: Amedeo Lonardo, Ashwani K. Singal, Natalia A. Osna, Kusum K. Kharbanda - Metabolism and Target Organ Damage 2022 被引用: 48

  22. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

    著者: Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo, Paola Loria - Digestive and Liver Disease 2014 被引用: 698

  23. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers

    著者: Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, Giovanni Targher - Metabolism 2024 被引用: 43

  24. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management

    著者: Amedeo Lonardo, Juan Pablo Arab, Marco Arrese - Advances in Therapy 2021 被引用: 92